PRedictive Genetic Testing On Macular Degeneration
Incorporate DNA Based AMD Testing In To Your Practice Today
We provide macular degeneration diagnosis tests and assessments needed for you to develop a personalized treatment plan for your patients.
Take The Lead in the Eye Care Field
Our AMD Predictive Genetics-based testing provides your practice with the most advanced use of genetic information combined with modifiable factors that allows you to provide a personalized treatment plan for your patients. Both our AMDiGuard Risk & AMD iGuard Progression provide you and your patient the information to develop a personalized treatment plan.
Genetic Macular Degeneration Diagnosis Testing For Your Patients
Earlier intervention leading to better outcomes
Preserve vision by delaying disease onset or slowing disease progression
Helping you determine a personalized patient management plan
May increase patient compliance to alter modifiable risk factors such as diet or smoking
Patient risk stratification
Clinically validated to provide a patient’s risk of AMD
WHAT CLINICIANS SAY
“Understanding genetic risk will impact management strategy on an individual basis. Doctor and patient can come up with some management strategies to decrease AMD risk.”
- Dr. Steve Ferrucci, OD, FAAO - Chief of Optometry at the Sepulveda VA
“We knew for years that family history of AMD is a “non-modifiable” risk factor, however until now we have not been able to know if any individual was or was not at higher risk for AMD. With Visible Genomics testing we can know if a particular patient is at higher risk for AMD or not, which should be a key component of any comprehensive AMD practice management system.”
- Dr. Barry Eiden, OD, FAAO - President and medical director of North Suburban Vision Consultants, Ltd
“Visible Genomics testing has transformed my macular degeneration practice from ‘wait and see’ to ‘predict and monitor.’ The Visible Genomics AMD genetic test tells me about my patients’ causative genes along with their protective genes. This gives me and my patients significant peace of mind when determining how often to monitor their condition. Implementing this AMD genetic testing protocol has contributed significantly to the success of my practice, both as a revenue center and also a patient loyalty builder.”
- Dr. James Hale - OD of Valley Eye Care
“Visible Genomics provides a streamlined service to elevate our level of patient care. We're glad to be partnered with them, and we feel great about being able to help our patients by optimizing treatment modalities for macular degeneration.”
- Dr. Steven Miller, Miller Vision Specialties, Greensboro, NC
We see the future of macular degeneration diagnosis testing and we know that a better day is on the horizon. We’ve spent two decades in the genetic and diagnostic industry using the latest technological advancements to transform the AMD Predictive Genetic Testing industry.